Biohaven Pharmaceutical (NYSE:BHVN) Price Target Raised to $76.00 at Morgan Stanley

Retrieved on: 2021-04-19 14:26:15

Tags for this article:

Click the tags to see associated articles and topics

Biohaven Pharmaceutical (NYSE:BHVN) Price Target Raised to $76.00 at Morgan Stanley. View article details on hiswai:

Excerpt

AQR Capital Management LLC now owns 25,487 shares of the company's stock valued at $1,657,000 after acquiring an additional 13,802 shares in the ...

Article found on: www.marketbeat.com